Insider Trading & Ownership - Rouan Sarah Kathryn

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Rouan Sarah Kathryn
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-03-31
Purchase(A)
2025-04-08
7:05 pm
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
1,240$24.15$29,9431,240
(Direct)
View
2025-03-31
Purchase
2025-04-02
6:29 pm
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
1,240$24.15$29,9431,240
(Direct)
View
2024-10-25
Sale
2024-10-25
7:28 pm
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
11,000$80.89$889,79011,000
(Direct)
View
2024-02-08
Sale
2024-02-08
7:38 pm
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
25,000$28.05$701,2500
(Direct)
View
2024-01-19
Sale
2024-01-19
8:35 pm
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
30,000$23.05$691,50025,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-01-02
Option Award
2025-01-06
8:11 pm
2026-01-02
2035-01-02
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
18,800$018,800
(Direct)
View
2024-10-25
Exercise
2024-10-25
7:28 pm
2023-01-03
2032-01-03
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
11,000$011,000
(Direct)
View
2024-10-25
Exercise
2024-10-25
7:28 pm
N/A
N/A
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
11,000$4.8811,000
(Direct)
View
2024-02-08
Exercise
2024-02-08
7:38 pm
N/A
N/A
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
25,000$8.320
(Direct)
View
2024-02-08
Exercise
2024-02-08
7:38 pm
2020-07-01
2029-07-01
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
25,000$00
(Direct)
View
2024-01-19
Exercise
2024-01-19
8:35 pm
N/A
N/A
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
30,000$8.3225,000
(Direct)
View
2024-01-19
Exercise
2024-01-19
8:35 pm
2020-07-01
2029-07-01
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
30,000$025,000
(Direct)
View
2024-01-02
Option Award
2024-01-04
9:25 pm
2025-01-02
2034-01-02
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
32,000$032,000
(Direct)
View
2023-01-03
Option Award
2023-01-04
6:11 pm
2024-01-03
2033-01-03
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
22,000$022,000
(Direct)
View
2022-01-03
Option Award
2022-01-05
7:10 pm
2023-01-03
2032-01-03
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
22,000$022,000
(Direct)
View
2021-06-30
Option Award
2021-07-07
5:46 pm
N/A
N/A
NAVIDEA BIOPHARMACEUTICALS INC.NAVBRouan Sarah Kathryn
Director
4,892$018,242
(Direct)
View
2021-01-13
Option Award
2021-01-14
4:38 pm
2022-01-13
2031-01-13
NAVIDEA BIOPHARMACEUTICALS INC.NAVBRouan Sarah Kathryn
Director
2,500$0.00115,850
(Direct)
View
2021-01-04
Option Award
2021-01-06
4:38 pm
2022-01-04
2031-01-04
Viking Therapeutics Inc.VKTXRouan Sarah Kathryn
Director
22,000$022,000
(Direct)
View
(A) Indicate amendment filing.